Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

538.29 +1.16 (+0.22%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today. 
Via InvestorPlace
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7." 
Via Benzinga
Are Wall Street Analysts Wrong About Eli Lilly Stock?
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Peering Into Eli Lilly's Recent Short Interest
Via Benzinga
Eli Lilly Unusual Options Activity
Via Benzinga
1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030
The stock has delivered market-beating returns in the past. It can do it again. 
Via The Motley Fool
The 7 Most Hated Stocks by Institutional Traders
Discover the surprising stocks institutional traders are selling, and find out what their moves could mean for your portfolio's future. 
Via InvestorPlace
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories
Benzinga 
Via Benzinga
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
Eli Lilly And Co (NYSE: LLY) has taken  
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
Are these highly successful stocks still good buys today? 
Via The Motley Fool
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years
Via Benzinga
2 Stocks That Moved the Market in August
These two stocks illustrate the most important trends in the market right now. 
Via The Motley Fool
Check Out What Whales Are Doing With LLY
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
The rhetoric surrounding popular businesses isn't always good advice. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
The company is toeing the finish line with a NASH treatment, an area of medicine marked by failures. 
Via Investor's Business Daily
The Gravity-Defying Lilly
Honestly, I’ve never seen anything like Eli Lilly before. All it does is go up, and up, and then up some more. It’s like how people are famous for being famous. This stock goes up because it goes up. 
Via Talk Markets
Should You Still Buy the S&P 500's Best-Performing August Stocks?
These high-flying S&P 500 stocks could have more room to run. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive... 
Via The Motley Fool
Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
Investors looking for exposure to a booming business should hitch their wagons to one of these leading pharmaceutical companies. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.
Mounjaro has been on the market for roughly one year and is already generating billions in sales for Eli Lilly. But with that said, its best days could be ahead. 
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
These healthcare stocks show no signs of slowing down. 
Via The Motley Fool
Only 2 Mega-Cap Monster Stocks Have Risen in Each of the Last 5 Years: Are They Buys Now?
There's no guarantee their winning streaks will continue. But don't be surprised if they do. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories
Benzinga 
Via Benzinga
UK Authority Recommends Eli Lilly's Famed Diabetes Drug Mounjaro As New Treatment Option For Type 2 Diabetes
UK's National Institute for Health and Care Excellence (NICE) has endorsed Eli Lilly And Co's (NYSE: LLY) diabetes medication, Mounjaro (tirzepatide), indicating it as a viable option for patients... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.